Rp loclzj tum spect 2 areas
CPT code 78831 covers a specialized nuclear medicine imaging procedure that uses radioactive tracers and SPECT (Single Photon Emission Computed Tomography) technology to locate tumors or abnormal tissue in two different areas of the body. This advanced 3D imaging helps doctors pinpoint exactly where cancer or other diseases are located.
This calculator gives a typical-case estimate using standard Medicare modifier rules. Actual payment depends on payer policies, documentation, code-specific CMS status indicators, and locality. Verify before billing.
RVU breakdown
Conversion factor: 32.3465 · Source: CMS MPFS RVU25A · Confidence: High
NCCI bundling edits
Loading bundling edits…
Billing tips
Always document both anatomic areas imaged with specific location descriptions (e.g., 'thorax and pelvis' not just 'two areas') in the radiology report
Impact: Prevents denials for insufficient documentation; estimated 15-20% denial rate reduction
Verify that SPECT imaging was actually performed and documented - planar-only imaging should be coded with 78830 or other appropriate codes
Impact: SPECT codes reimburse significantly higher; incorrect upcoding can trigger $612.97 overpayment recovery plus penalties
Bill radiopharmaceutical separately using appropriate A9xxx HCPCS codes (e.g., A9562 for Tc-99m Mertiatide) as 78831 covers only the imaging service
Impact: Additional $150-$800 reimbursement depending on radiopharmaceutical used
For Medicare patients, ensure medical necessity documentation includes cancer diagnosis or suspected malignancy with specific ICD-10 codes
Impact: Prevents medical necessity denials which account for approximately 25% of nuclear medicine claim rejections
When performed same day as other imaging, append modifier 59 only if truly distinct and separate from other procedures; document separate clinical indication
Impact: Improper modifier 59 use risks audit flags; proper use protects $612.97 payment from bundling
Verify that pre-authorization was obtained before scheduling as most commercial payers require it for SPECT tumor imaging
Impact: Prevents 100% denial of $612.97 charge; pre-auth denials are difficult to overturn retrospectively
Real billers contribute denial patterns and appeal strategies for this code. Once 5+ reports come in, you’ll see live aggregated data here — the only place this exists, free.
Get the free Revenue Protection Toolkit — the denial triggers, modifier pitfalls, and bundling conflicts that quietly cost you reimbursement. Instant download.
Help build the field knowledge
MedPayIQ gets smarter as billers contribute. If you've had this code denied, share what happened so others learn from it. Anonymous, no patient info.